Clinical human trials begin for COVID-19 vaccine in China

[JSCh]

WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic

CoronaVac is one of two Chinese vaccines already sustaining vaccination campaigns in more than 70 nations. Both should soon be much more widely available to low-income countries.

www.nature.com

 

[JSCh]

https://twitter.com/x/status/1397066010318884865

People's Daily, China @PDChina
China state-affiliated media

China's Kangtai Bio on Monday signed a deal with Chilean institutions to carry out the Phase III clinical trials in Chile for inactivated #COVID19 vaccine. Kangtai Bio vaccine has been approved for emergency use in China.


1:44 PM · May 25, 2021

https://twitter.com/x/status/1401114445930065920

CGTN @CGTNOfficial
China state-affiliated media

Malaysian Health Ministry announced on Saturday that the country has approved the Phase-III clinical trial for the inactivated #COVID19 vaccine developed by #China's Shenzhen Kangtai Biological Products Co., Ltd.


5:51 PM · Jun 5, 2021

 

[JSCh]

https://twitter.com/x/status/1401814677273735169

Hilda Bastian, PhD @hildabast

Sinovac has registered a very large safety study in China for CoronaVac: 121,000 people, including at least 4,000 aged 60+

ClinicalTrials.gov

clinicaltrials.gov

4:13 PM · Jun 7, 2021

 

[JSCh]

https://twitter.com/x/status/1401114445930065920

CGTN @CGTNOfficial
China state-affiliated media

Malaysian Health Ministry announced on Saturday that the country has approved the Phase-III clinical trial for the inactivated #COVID19 vaccine developed by #China's Shenzhen Kangtai Biological Products Co., Ltd.


5:51 PM · Jun 5, 2021

https://twitter.com/x/status/1402243854263271430

Medical Xpress @physorg_health

A novel #vaccine against COVID-19 is safe and induces antibody production

A novel vaccine against COVID-19 is safe and induces antibody production

The COVID-19 pandemic continues to disrupt and end lives around the world, and public health officials worldwide have recognized vaccines as the critical tools required for controlling the COVID-19 death toll and achieving a return to normal life. Several vaccines against COVID-19 are already in...

medicalxpress.com

8:39 PM · Jun 8, 2021

 

[JSCh]

https://twitter.com/x/status/1403162568814862338

https://twitter.com/x/status/1403264488967741441

China Economy @CE_ChinaEconomy
China state-affiliated media

#China has approved a 7th domestically developed #COVID19 #vaccine to meet increasing demand amid China's accelerating mass #vaccination drive. Latest approved vaccine was developed by Institute of Medical Biology of Chinese Academy of Medical Sciences based in Kunming, Yunnan.

 

[JSCh]

Look like is Fosun is looking to cash in on its investment.
One of the difference between Fosun/BioNTech mRNA and China's own Walvax mRNA vaccine currently starting clinical trial oversea is that Walvax vaccine can be stored at room temperature for at least 1 week versus Fosun/BioNTech that require expensive special refrigerator for storage and transportation.
Walvax factory for 120 million per annual is also projected to be finish by end of this year.
Therefore it isn't surprising that Fosun would want to get their vaccine approved and in market as soon as possible. However, the report below did not mention how long their factory could begin production.

https://twitter.com/x/status/1391810234239303683

https://twitter.com/x/status/1403566544219639810

Global Times @globaltimesnews
China state-affiliated media

Production line of the COVID-19 mRNA vaccine co-developed by German-based BioNTech and China's Fosun Pharma is expected to be completed in China as early as August, which paves the way for mass production of the vaccine, said Fosun chairman.

Production line of mRNA vaccine co-developed by BioNTech and Fosun expected to be completed by August: Fosun chairman - Global Times

www.globaltimes.cn

12:15 PM · Jun 12, 2021

 

[JSCh]

China has shipped lots of vaccine to the world, but I think this one is a bit surprising that it occur so late.

https://twitter.com/x/status/1406549932786339841

CGTN @CGTNOfficial
China state-affiliated media

Batch of Sinopharm COVID-19 vaccines arrive in Vietnam https://bit.ly/3cSVa3Q


5:50 PM · Jun 20, 2021

 

[JSCh]

GLOBALink | China hits 400 mln vaccine doses following recent COVID-19 outbreak

More than 100 million doses of the vaccine in the past nine days, 11 million doses a day.

China now has reach and surpass the milestone of 1 billion on saturday !

 

[JSCh]

Goal is reached: 40 per cent of Chinese get Covid-19 jab before end of June

More than 1.12 billion doses have been administered and 630 million people inoculated.

www.scmp.com

 

[JSCh]

https://twitter.com/x/status/1408632756049891333

Global Times @globaltimesnews
China state-affiliated media

China’s #Sinovac vaccine production line in #Egypt will soon be put into operation. Local health official said that the local plant will produce over 40 million doses within a year.

Sinovac vaccine production line in Egypt to start operating soon - Global Times

www.globaltimes.cn

11:46 AM · Jun 26, 2021

 

[JSCh]

https://twitter.com/x/status/1409662965301669892

Global Times @globaltimesnews
China state-affiliated media

Lancet Infect Dis released the world first trial result on minors aged 3-17 Tuesday. It showed China’s #Sinovac #COVID19 vaccine was well tolerated and safe and induced humoral responses in children and adolescents aged 3–17 years.


8:00 AM · Jun 29, 2021

https://twitter.com/x/status/1409674906959179779

 

[JSCh]

https://twitter.com/x/status/1374677438962221059

Clover Biopharmaceuticals @CloverBiopharma

Today, we are happy to announce the launch of our Phase 2/3 #ClinicalTrial, SPECTRA, with the dosing of our first participants. The goal of this study is to further test the efficacy, safety and immunogenicity of our S-Trimmer COVID-19 vaccine.
Learn more: https://prn.to/3scB7Db


7:00 PM · Mar 24, 2021

https://twitter.com/x/status/1410191440722997249

Clover Biopharmaceuticals @CloverBiopharma

We are excited to announce that we have entered into an advance purchase agreement with @gavi and will provide up to 414 million doses of our protein-based #COVID19 #vaccine candidate for procurement through the COVAX Facility. Learn more here: https://prn.to/3dsQoKW

https://twitter.com/x/status/1410198954206244866

https://twitter.com/x/status/1410243015436820485

https://twitter.com/x/status/1410243018112835584

 

[JSCh]

https://twitter.com/x/status/1412882866971635713

NEJM @NEJM

In a study involving 10.2 million participants in Chile, the effectiveness of an inactivated, China-developed #SARSCoV2 vaccine was estimated. Effectiveness was 65.9% for infection, 87.5% for hospitalization, 90.3% for ICU admission, and 86.3% for death.

 

[JSCh]

https://twitter.com/x/status/1413562366890061828

Reuters Health @Reuters_Health

A potential COVID-19 vaccine developed by a subsidiary of China's Livzon Pharmaceutical Group Inc (http://000513.SZ) appeared safe and able to elicit antibodies in healthy adults in a mid-stage clinical trial, Chinese researchers said.

 

[JSCh]

https://twitter.com/x/status/1414500763871584257

Hilda Bastian, PhD @hildabast

1.382 billion doses of Covid vax reportedly administered in China as of July 11
https://reuters.com/world/china/china-administered-total-1382-bln-doses-covid-19-vaccines-by-july-11-2021-07-12/…
Population is 1.4b. Vax from age 3 on the horizon (with inactivated vaxes from Sinovac & Sinopharm)

China's children may be next in line for COVID-19 vaccines

If China is to meet its tentative goal of vaccinating 80% of its population against the coronavirus by the end of the year, tens of millions of children are going to have to start rolling up their sleeves.

apnews.com

4:23 PM · Jul 12, 2021